Εζετιμίμπη (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Εζετιμίμπη" in Greek language version.

refsWebsite

Global rank Greek rank

15nih.gov

4^th place

10doi.org

2^nd place

3^rd place

2drugs.com

399^th place

130^th place

2clincalc.com

3,912^th place

594^th place

1worldcat.org

5^th place

8^th place

1web.archive.org

1^st place

1nice.org.uk

3,258^th place

2,509^th place

1fda.gov

447^th place

368^th place

clincalc.com

«The Top 300 of 2020». ClinCalc. Ανακτήθηκε στις 11 Απριλίου 2020.
«Ezetimibe - Drug Usage Statistics». ClinCalc. Ανακτήθηκε στις 11 Απριλίου 2020.

doi.org

dx.doi.org

«Effect of Ezetimibe Monotherapy on Plasma Lipoprotein(a) Concentrations in Patients with Primary Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials». Drugs 78 (4): 453–462. March 2018. doi:10.1007/s40265-018-0870-1. PMID 29396832.
«Safety and efficacy of ezetimibe: A meta-analysis». Int. J. Cardiol. 201: 247–52. December 2015. doi:10.1016/j.ijcard.2015.08.103. PMID 26301648.
«Ezetimibe therapy: mechanism of action and clinical update». Vasc Health Risk Manag 8: 415–27. 2012. doi:10.2147/VHRM.S33664. PMID 22910633.
Cannon, Christopher P. (June 18, 2015). «Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes». New England Journal of Medicine 372 (25): 2387–2397. doi:10.1056/NEJMoa1410489. PMID 26039521.
Alenghat, Francis J.; Davis, Andrew M. (2019). «Management of Blood Cholesterol». JAMA 321 (8): 800–801. doi:10.1001/jama.2019.0015. ISSN 0098-7484. PMID 30715135.
«ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)». Atherosclerosis 217 (1): 3–46. July 2011. doi:10.1016/j.atherosclerosis.2011.06.011. PMID 21882396.
«Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version». J. Atheroscler. Thromb. 20 (6): 517–23. 2013. doi:10.5551/jat.15792. PMID 23665881.
Expert Dyslipidemia Panel of the International Atherosclerosis Society Panel members (2014). «An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia--full report». J Clin Lipidol 8 (1): 29–60. doi:10.1016/j.jacl.2013.12.005. PMID 24528685.
«Ezetimibe decreased nonalcoholic fatty liver disease activity score but not hepatic steatosis». Korean J. Intern. Med. 34 (2): 296–304. 2019. doi:10.3904/kjim.2017.194. PMID 29551054.
SJS Basha; SA Naveed; NK Tiwari; D Shashikumar; S Muzeeb; TR Kumar; NV Kumar; NP Rao και άλλοι. (2007). «Mechanism of Drug-Drug Interactions Between Warfarin and Statins». Journal of Chromatography B 853 (1): 88–96. doi:10.1016/j.jchromb.2007.02.053. PMID 17442643.

drugs.com

«Ezetimibe Monograph for Professionals». Drugs.com. American Society of Health-System Pharmacists. Ανακτήθηκε στις 13 Απριλίου 2019.
«Ezetimibe (Zetia) Use During Pregnancy». Drugs.com. Ανακτήθηκε στις 13 Απριλίου 2019.

fda.gov

accessdata.fda.gov

Zetia label, Rev 23. Revised: January 2012

nice.org.uk

«Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease | Guidance and guidelines | NICE». Αρχειοθετήθηκε από το πρωτότυπο στις 19 Νοεμβρίου 2014.

nih.gov

ncbi.nlm.nih.gov

«Effect of Ezetimibe Monotherapy on Plasma Lipoprotein(a) Concentrations in Patients with Primary Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials». Drugs 78 (4): 453–462. March 2018. doi:10.1007/s40265-018-0870-1. PMID 29396832.
«Safety and efficacy of ezetimibe: A meta-analysis». Int. J. Cardiol. 201: 247–52. December 2015. doi:10.1016/j.ijcard.2015.08.103. PMID 26301648.
«Ezetimibe therapy: mechanism of action and clinical update». Vasc Health Risk Manag 8: 415–27. 2012. doi:10.2147/VHRM.S33664. PMID 22910633.
Cannon, Christopher P. (June 18, 2015). «Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes». New England Journal of Medicine 372 (25): 2387–2397. doi:10.1056/NEJMoa1410489. PMID 26039521.
Alenghat, Francis J.; Davis, Andrew M. (2019). «Management of Blood Cholesterol». JAMA 321 (8): 800–801. doi:10.1001/jama.2019.0015. ISSN 0098-7484. PMID 30715135.
«ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)». Atherosclerosis 217 (1): 3–46. July 2011. doi:10.1016/j.atherosclerosis.2011.06.011. PMID 21882396.
«Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version». J. Atheroscler. Thromb. 20 (6): 517–23. 2013. doi:10.5551/jat.15792. PMID 23665881.
Expert Dyslipidemia Panel of the International Atherosclerosis Society Panel members (2014). «An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia--full report». J Clin Lipidol 8 (1): 29–60. doi:10.1016/j.jacl.2013.12.005. PMID 24528685.
«Ezetimibe decreased nonalcoholic fatty liver disease activity score but not hepatic steatosis». Korean J. Intern. Med. 34 (2): 296–304. 2019. doi:10.3904/kjim.2017.194. PMID 29551054.
SJS Basha; SA Naveed; NK Tiwari; D Shashikumar; S Muzeeb; TR Kumar; NV Kumar; NP Rao και άλλοι. (2007). «Mechanism of Drug-Drug Interactions Between Warfarin and Statins». Journal of Chromatography B 853 (1): 88–96. doi:10.1016/j.jchromb.2007.02.053. PMID 17442643.

pubmedcentral.nih.gov

«Ezetimibe therapy: mechanism of action and clinical update». Vasc Health Risk Manag 8: 415–27. 2012. doi:10.2147/VHRM.S33664. PMID 22910633.
Alenghat, Francis J.; Davis, Andrew M. (2019). «Management of Blood Cholesterol». JAMA 321 (8): 800–801. doi:10.1001/jama.2019.0015. ISSN 0098-7484. PMID 30715135.
«Ezetimibe decreased nonalcoholic fatty liver disease activity score but not hepatic steatosis». Korean J. Intern. Med. 34 (2): 296–304. 2019. doi:10.3904/kjim.2017.194. PMID 29551054.

nlm.nih.gov

U.S. National Library of Medicine, National Institutes of Health, U.S. Department of Health and Human Services. Page last updated: 27 October 2014 Medline Plus: Ezetimibe

toxnet.nlm.nih.gov

«Ezetimibe - National Library of Medicine HSDB Database». toxnet.nlm.nih.gov. National Library of Medicine. Ανακτήθηκε στις 29 Μαΐου 2018.

web.archive.org

«Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease | Guidance and guidelines | NICE». Αρχειοθετήθηκε από το πρωτότυπο στις 19 Νοεμβρίου 2014.

worldcat.org

Alenghat, Francis J.; Davis, Andrew M. (2019). «Management of Blood Cholesterol». JAMA 321 (8): 800–801. doi:10.1001/jama.2019.0015. ISSN 0098-7484. PMID 30715135.